Total Payments
$3,540
2021 Payments
$674.80
Companies
29
Transactions
73
Medicare Patients
4,412
Medicare Billing
$573,405
Payment Breakdown by Category
Travel$2,114 (59.7%)
Food & Beverage$1,141 (32.2%)
Consulting$150.00 (4.2%)
Education$134.97 (3.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $2,114 | 11 | 59.7% |
| Food and Beverage | $1,141 | 57 | 32.2% |
| Consulting Fee | $150.00 | 1 | 4.2% |
| Education | $134.97 | 4 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $2,114 | 11 | $0 (2021) |
| COMSORT, Inc | $150.00 | 1 | $0 (2018) |
| Janssen Biotech, Inc. | $139.18 | 11 | $0 (2021) |
| Janssen Scientific Affairs, LLC | $132.87 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $116.57 | 1 | $0 (2017) |
| Lilly USA, LLC | $87.94 | 5 | $0 (2020) |
| JAZZ PHARMACEUTICALS INC. | $62.60 | 2 | $0 (2021) |
| Exelixis Inc. | $59.74 | 3 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $58.26 | 2 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $55.96 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $674.80 | 7 | Intuitive Surgical, Inc. ($569.80) |
| 2020 | $130.63 | 6 | E.R. Squibb & Sons, L.L.C. ($38.14) |
| 2019 | $1,095 | 18 | Intuitive Surgical, Inc. ($833.85) |
| 2018 | $1,283 | 29 | Intuitive Surgical, Inc. ($710.42) |
| 2017 | $356.27 | 13 | Novartis Pharmaceuticals Corporation ($116.57) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/16/2021 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $550.80 | General |
| Category: SURGERY | ||||||
| 07/16/2021 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $19.00 | General |
| Category: SURGERY | ||||||
| 06/21/2021 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: Oncology | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 04/19/2021 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2021 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: Oncology | ||||||
| 01/19/2021 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Food and Beverage | Cash or cash equivalent | $33.83 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/14/2020 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $14.02 | General |
| Category: Hematology/Oncology | ||||||
| 10/19/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $38.14 | General |
| Category: Oncology | ||||||
| 09/21/2020 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $17.52 | General |
| Category: Oncology | ||||||
| 08/17/2020 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $27.65 | General |
| Category: Oncology | ||||||
| 07/18/2020 | Lilly USA, LLC | RETEVMO (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Oncology | ||||||
| 01/21/2020 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Oncology | ||||||
| 12/20/2019 | Lilly USA, LLC | ALIMTA (Drug), CYRAMZA, VERZENIO | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Oncology | ||||||
| 12/16/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Oncology | ||||||
| 11/18/2019 | Agios Pharmaceuticals, Inc. | TIBSOVO (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.77 | General |
| 11/07/2019 | Dova Pharmaceuticals | Doptelet (Drug) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Hepatology | ||||||
| 10/23/2019 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Food and Beverage | Cash or cash equivalent | $28.77 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2019 | Lilly USA, LLC | ALIMTA (Drug), CYRAMZA, VERZENIO | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Oncology | ||||||
| 09/16/2019 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: ONCOLOGY | ||||||
| 08/19/2019 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Virology | ||||||
| 07/15/2019 | PFIZER INC. | TALZENNA (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: ONCOLOGY | ||||||
| 06/10/2019 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $365.28 | General |
| Category: SURGERY | ||||||
| 05/20/2019 | Genentech USA, Inc. | Perjeta (Biological), Kadcyla | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 35 | 1,715 | 11,925 | $545,033 | $112,408 |
| 2020 | 57 | 2,697 | 32,327 | $2.1M | $460,997 |
Total Patients
4,412
Total Services
44,252
Medicare Billing
$573,405
Procedure Codes
92
All Medicare Procedures & Services
92 procedure records from CMS Medicare Utilization — Page 2 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 82232 | Beta-2 microglobulin (protein) level | Office | 2021 | 24 | 31 | $2,976 | $501.58 | 16.9% |
| 86300 | Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | Office | 2021 | 23 | 24 | $3,072 | $499.44 | 16.3% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2021 | 36 | 76 | $2,584 | $491.72 | 19.0% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis | Office | 2021 | 13 | 23 | $2,300 | $428.72 | 18.6% |
| 85007 | Microscopic examination for white blood cells with manual cell count | Office | 2021 | 36 | 76 | $1,672 | $288.80 | 17.3% |
| 83550 | Iron binding capacity | Office | 2021 | 24 | 30 | $1,050 | $262.20 | 25.0% |
| 83540 | Iron level | Office | 2021 | 29 | 35 | $945.00 | $226.45 | 24.0% |
| 96361 | Hydration infusion into a vein | Office | 2021 | 11 | 14 | $1,050 | $162.82 | 15.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 16 | 262 | $262.00 | $30.78 | 11.7% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2021 | 18 | 25 | $175.00 | $16.62 | 9.5% |
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2020 | 12 | 4,000 | $488,800 | $159,547 | 32.6% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2020 | 20 | 17,055 | $341,100 | $50,585 | 14.8% |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2020 | 12 | 1,200 | $259,440 | $37,860 | 14.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 181 | 370 | $136,160 | $30,009 | 22.0% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2020 | 26 | 169 | $27,040 | $26,835 | 99.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 12 | 1,680 | $89,460 | $26,028 | 29.1% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 104 | 212 | $149,884 | $25,023 | 16.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 115 | 262 | $65,500 | $14,946 | 22.8% |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | Office | 2020 | 23 | 34 | $51,054 | $11,379 | 22.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 250 | 904 | $32,544 | $6,964 | 21.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2020 | 76 | 100 | $31,300 | $5,845 | 18.7% |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | Office | 2020 | 84 | 212 | $33,284 | $5,484 | 16.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2020 | 184 | 482 | $30,848 | $5,041 | 16.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 19 | 37 | $18,352 | $4,265 | 23.2% |
| 85055 | Reticulated (young) platelet measurement | Office | 2020 | 40 | 107 | $15,301 | $3,807 | 24.9% |
About Dr. Richard Helmer, M.D
Dr. Richard Helmer, M.D is a Hematology & Oncology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447293899.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Helmer, M.D has received a total of $3,540 in payments from pharmaceutical and medical device companies, with $674.80 received in 2021. These payments were reported across 73 transactions from 29 companies. The most common payment nature is "Travel and Lodging" ($2,114).
As a Medicare-enrolled provider, Helmer has provided services to 4,412 Medicare beneficiaries, totaling 44,252 services with total Medicare billing of $573,405. Data is available for 2 years (2020–2021), covering 92 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Austin, TX
- Active Since 06/14/2006
- Last Updated 05/27/2009
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1447293899
Products in Payments
- Da Vinci Surgical System (Device) $2,114
- KEYTRUDA (Biological) $197.09
- DARZALEX (Biological) $155.46
- RYDAPT (Drug) $116.57
- IMBRUVICA (Drug) $101.31
- VYXEOS (Drug) $62.60
- Cabometyx (Drug) $59.74
- NINLARO (Drug) $46.25
- OPDIVO (Biological) $38.14
- CYRAMZA (Drug) $37.97
- Imbruvica (Drug) $34.00
- ALIMTA (Drug) $32.37
- JAKAFI (Drug) $32.20
- Lonsurf (Drug) $31.93
- PADCEV (Biological) $27.65
- TALZENNA (Drug) $27.49
- Xofigo (Drug) $26.45
- Perjeta (Biological) $26.32
- IMFINZI (Biological) $25.88
- TIBSOVO (Drug) $25.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Austin
Dr. Debra Patt, Md, Mph, MD, MPH
Hematology & Oncology — Payments: $109,909
Hematology & Oncology $109,909
Uttam Rao
Hematology & Oncology — Payments: $19,966
Hematology & Oncology $19,966
Dr. Allison Gorrebeeck, Md, MD
Hematology & Oncology — Payments: $5,624
Hematology & Oncology $5,624
Vinod Kondragunta
Hematology & Oncology — Payments: $3,490
Hematology & Oncology $3,490
Dr. Shubhada Shrikhande, Md, MD
Hematology & Oncology — Payments: $1,469
Hematology & Oncology $1,469
Sheena Sahota, M.d, M.D
Hematology & Oncology — Payments: $1,424
Hematology & Oncology $1,424